A Multicentre, Double-Blind, Placebo-Controlled,...

  • Main
  • 2020 / 8
  • A Multicentre, Double-Blind, Placebo-Controlled,...
Inflammatory Intestinal Diseases 2020 / 8

A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis

Radeke, Heinfried H., Stein, Jürgen, Van Assche, Gert, Rogler, Gerhard, Lakatos, Peter L., Muellershausen, Florian, Moulin, Pierre, Jarvis, Philip, Colin, Laurence, Gergely, Peter, Kruis, Wolfgang
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Inflammatory Intestinal Diseases
DOI:
10.1159/000509393
Date:
August, 2020
File:
PDF, 438 KB
2020
Conversion to is in progress
Conversion to is failed